뇌심부자극 기기 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of deep brain stimulation devices Market

The global deep brain stimulation devices market size was valued at USD 1.56 billion in 2025 and is projected to grow from USD 1.74 billion in 2026 to USD 4.20 billion by 2034, exhibiting a CAGR of 11.60% during the forecast period. North America dominated the market with a 46.44% market share in 2025. The market is witnessing strong growth due to the rising prevalence of neurological disorders, increasing geriatric population, technological advancements in neuromodulation, and growing demand for minimally invasive surgical procedures.

Deep brain stimulation (DBS) is a surgical treatment in which an implanted device delivers electrical impulses to targeted areas of the brain. A DBS system generally consists of a neurostimulator, extension, and lead. These systems are widely used to manage symptoms associated with Parkinson's disease, dystonia, and essential tremor. Increasing awareness regarding advanced treatment options and the ability of DBS therapy to reduce symptoms and medication dependence are supporting market expansion.

Market Definition and Scope

The deep brain stimulation devices market includes systems and associated components used to deliver controlled electrical stimulation to specific brain regions for managing neurological and movement disorders. The market is analyzed based on product type, application, end user, and region. Growing healthcare expenditure, expanding neurosurgical capabilities, and increasing investments in neurological treatment technologies are expected to create further opportunities through 2034.

Market Dynamics

Drivers

Rising Demand for Minimally Invasive Surgical Procedures

The increasing preference for minimally invasive procedures is a major factor supporting DBS market growth. Deep brain stimulation provides a targeted treatment approach for conditions such as Parkinson's disease, dystonia, and essential tremor. Compared with conventional surgical procedures, minimally invasive techniques can offer benefits such as smaller incisions, reduced scarring, lower postoperative discomfort, and faster recovery. These advantages are increasing patient and physician interest in advanced neurosurgical procedures.

Growing Geriatric Population

The expanding elderly population is another important growth driver. Older adults are more susceptible to neurological disorders, including Parkinson's disease and other movement-related conditions. The increasing number of elderly individuals worldwide is consequently expanding the potential patient pool for DBS therapy. Greater awareness of neurological diseases and improvements in diagnosis are also encouraging more patients to seek specialized treatment.

Trends

Technological advancement is an important trend shaping the market. Manufacturers are developing sophisticated DBS systems with improved stimulation control, directional leads, and more personalized treatment capabilities. Dual-channel systems are gaining attention because they can facilitate bilateral stimulation and provide physicians with greater flexibility in therapy delivery.

Restraints

The high cost associated with DBS systems, surgical procedures, specialized medical infrastructure, and postoperative monitoring can limit adoption, particularly in developing economies. In addition, the requirement for highly trained neurosurgeons and specialized treatment centers may restrict access to DBS therapy in regions with limited healthcare infrastructure.

Impact of COVID-19

The COVID-19 pandemic temporarily affected the market as hospitals prioritized emergency procedures and several elective neurological surgeries were postponed. Disruptions in medical-device supply chains and reduced hospital visits also affected procedure volumes. However, the recovery of healthcare systems and resumption of elective surgeries supported market stabilization. Increasing investment in specialized neurological care is expected to strengthen market development during the forecast period.

Segmentation Analysis

By Product Type

The market is segmented into dual-channel deep brain stimulators and single-channel deep brain stimulators. The dual-channel segment held the leading position in 2025, supported by technological advancements and increasing adoption of systems capable of providing stimulation through multiple leads. Improvements in directional stimulation and personalized therapy are expected to strengthen demand.

Single-channel systems are expected to witness steady growth because of their comparatively simpler technology and affordability. Their adoption may remain relevant in developing healthcare markets where cost considerations influence treatment decisions.

By Application

Based on application, the market is divided into Parkinson's disease, dystonia, essential tremor, and others. Parkinson's disease represented the leading application segment in 2025 because of the large patient population and increasing demand for advanced symptom-management therapies. Growing awareness and healthcare expenditure are expected to further support DBS adoption.

Dystonia and essential tremor are also expected to experience steady expansion as diagnosis improves and awareness of DBS treatment increases.

By End User

By end user, the market is categorized into hospitals, specialty clinics, and others. Hospitals accounted for the dominant position because DBS surgeries require advanced infrastructure, highly trained specialists, precision equipment, and comprehensive postoperative care. Specialty clinics are expected to expand as specialized neurological treatment centers become more prevalent.

Regional Insights

North America

North America led the deep brain stimulation devices market in 2025, supported by advanced healthcare infrastructure, strong research and development activities, and the presence of major manufacturers. The North America market size reached USD 323.4 million in 2025. Increasing adoption of advanced DBS therapies and a growing neurological patient population are expected to sustain regional growth.

Asia Pacific

Asia Pacific is expected to witness rapid market expansion through 2034. Increasing healthcare expenditure, improving medical infrastructure, rising awareness of neurological disorders, and growing adoption of specialized hospitals are supporting demand. Japan, China, and India are expected to remain important markets.

Europe

Europe is projected to experience significant growth due to the prevalence of neurological disorders and the availability of advanced healthcare facilities. Germany, the U.K., and France are expected to contribute substantially to regional expansion.

Competitive Landscape

The market is relatively consolidated, with major companies focusing on technological development, product launches, strategic partnerships, and acquisitions. Key companies include Abbott, Medtronic, Boston Scientific Corporation, and Beijing PINS Medical Co., Ltd. Medtronic maintains a strong position through its neuromodulation portfolio and continued investment in DBS technologies. Boston Scientific has expanded its portfolio with systems incorporating directional lead technologies, while Abbott has strengthened its medical-device capabilities through strategic acquisitions.

Report Coverage

The deep brain stimulation devices market analysis provides a comprehensive assessment of market size, market value, segmentation, regional developments, competitive dynamics, technological advancements, and industry trends. The study evaluates the market across product type, application, and end-user categories while examining growth opportunities across North America, Europe, Asia Pacific, and other regions. It also highlights strategic developments, product launches, mergers and acquisitions, and technological innovations influencing the market.

Conclusion

The deep brain stimulation devices market is positioned for strong growth from 2025 through 2034, with market size expected to increase from USD 1.56 billion in 2025 to USD 4.20 billion by 2034. Rising neurological disorders, an aging population, growing preference for minimally invasive procedures, and advancements in DBS technology will remain key factors supporting market expansion. North America is expected to retain a strong position, while Asia Pacific offers significant future opportunities due to improving healthcare infrastructure and increasing awareness.

Unit Value (USD million)

Segmentation By Product Type

• Dual Channel Deep Brain stimulators
• Single Channel Deep Brain Stimulators

By Application

• Parkinson's Disease
• Dystonia
• Essential Tremor
• Others

By End User

• Hospitals
• Specialty Clinics
• Others

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East and Africa ( South Africa, GCC, and Rest of the Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Industry Background of Deep Brain Stimulation Devices Market
• 4.2. New Product Launch
• 4.3. Porter's five forces analysis
• 4.4. Key Merger and Acquisition Strategies by Top Players
• 4.5. Overview on Technological Advancements Pertaining to the Deep Brain Stimulators

5. Global Deep Brain Stimulation (DBS) Devices Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product Type
  • 5.2.1. Dual Channel Deep Brain stimulators
  • 5.2.2. Single Channel Deep Brain Stimulators
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Parkinson's Disease
  • 5.3.2. Dystonia
  • 5.3.3. Essential Tremor
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals
  • 5.4.2. Specialty Clinics
  • 5.4.3. Others
• 5.5. Market Analysis, Insights and Forecast - By Country
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Deep Brain Stimulation (DBS) Devices Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis - By Product Type
  • 6.2.1. Dual Channel Deep Brain stimulators
  • 6.2.2. Single Channel Deep Brain Stimulators
• 6.3. Market Analysis - By Application
  • 6.3.1. Parkinson's Disease
  • 6.3.2. Dystonia
  • 6.3.3. Essential Tremor
  • 6.3.4. Others
• 6.4. Market Analysis - By End User
  • 6.4.1. Hospitals
  • 6.4.2. Specialty Clinics
  • 6.4.3. Others
• 6.5. Market Analysis - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Deep Brain Stimulation (DBS) Devices Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis - By Product Type
  • 7.2.1. Dual Channel Deep Brain stimulators
  • 7.2.2. Single Channel Deep Brain Stimulators
• 7.3. Market Analysis - By Application
  • 7.3.1. Parkinson's Disease
  • 7.3.2. Dystonia
  • 7.3.3. Essential Tremor
  • 7.3.4. Others
• 7.4. Market Analysis - By End User
  • 7.4.1. Hospitals
  • 7.4.2. Specialty Clinics
  • 7.4.3. Others
• 7.5. Market Analysis - By Country
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Deep Brain Stimulation (DBS) Devices Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis - By Product Type
  • 8.2.1. Dual Channel Deep Brain stimulators
  • 8.2.2. Single Channel Deep Brain Stimulators
• 8.3. Market Analysis - By Application
  • 8.3.1. Parkinson's Disease
  • 8.3.2. Dystonia
  • 8.3.3. Essential Tremor
  • 8.3.4. Others
• 8.4. Market Analysis - By End User
  • 8.4.1. Hospitals
  • 8.4.2. Specialty Clinics
  • 8.4.3. Others
• 8.5. Market Analysis - By Country
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Deep Brain Stimulation (DBS) Devices Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis - By Product Type
  • 9.2.1. Dual Channel Deep Brain stimulators
  • 9.2.2. Single Channel Deep Brain Stimulators
• 9.3. Market Analysis - By Application
  • 9.3.1. Parkinson's Disease
  • 9.3.2. Dystonia
  • 9.3.3. Essential Tremor
  • 9.3.4. Others
• 9.4. Market Analysis - By End User
  • 9.4.1. Hospitals
  • 9.4.2. Specialty Clinics
  • 9.4.3. Others
• 9.5. Market Analysis - By Country
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Deep Brain Stimulation (DBS) Devices Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis - By Product Type
  • 10.2.1. Dual Channel Deep Brain stimulators
  • 10.2.2. Single Channel Deep Brain Stimulators
• 10.3. Market Analysis - By Application
  • 10.3.1. Parkinson's Disease
  • 10.3.2. Dystonia
  • 10.3.3. Essential Tremor
  • 10.3.4. Others
• 10.4. Market Analysis - By End User
  • 10.4.1. Hospitals
  • 10.4.2. Specialty Clinics
  • 10.4.3. Others
• 10.5. Market Analysis - By Country
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles
  • 11.5.1. Abbott (ST. JUDE MEDICAL)
    • 11.5.1.1. Overview,
    • 11.5.1.2. Products & services,
    • 11.5.1.3. SWOT analysis,
    • 11.5.1.4. Recent developments,
    • 11.5.1.5. strategies,
    • 11.5.1.6. financials (based on availability)
  • 11.5.2. Medtronic
    • 11.5.2.1. Overview,
    • 11.5.2.2. Products & services,
    • 11.5.2.3. SWOT analysis,
    • 11.5.2.4. Recent developments,
    • 11.5.2.5. strategies,
    • 11.5.2.6. financials (based on availability)
  • 11.5.3. Boston Scientific Corporation
    • 11.5.3.1. Overview,
    • 11.5.3.2. Products & services,
    • 11.5.3.3. SWOT analysis,
    • 11.5.3.4. Recent developments,
    • 11.5.3.5. strategies,
    • 11.5.3.6. financials (based on availability)
  • 11.5.4. Beijing PINS Medical Co., Ltd.
    • 11.5.4.1. Overview,
    • 11.5.4.2. Products & services,
    • 11.5.4.3. SWOT analysis,
    • 11.5.4.4. Recent developments,
    • 11.5.4.5. strategies,
    • 11.5.4.6. financials (based on availability)

12. Strategic Recommendations